How should pharmaceuticals harness the power of AI to transform clinical trials?

December 19, 2018

"Big data and AI have the potential to make clinical trials more effective, efficient and equitable," according to Roy Smythe, Chief Medical Officer, Strategy and Partnerships for Philips, at the time of filming. Therapeutics companies are struggling to recruit enough participants for clinical trials, but by using AI to create digital twins to plug this shortfall, potentially life-saving drugs can be put on the market quicker.

Spotlight

USP Zdrowie

USP Health is a market leader in over the counter and over-the-counter (OTC) markets in Poland. The company's portfolio includes well-known brands. Apap, Ibuprom, Gripex, Verdin, Stoperan and Xenna.

OTHER VIDEOS

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

EMBL researchers identifying how potential drugs work in the fight against COVID-19

video | April 16, 2020

EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells. This will help them to quickly identify other drugs that could treat the disease, which are urgently needed until a vaccine is developed, and possibly afterwards as well....

Watch Now

Why the War on Drugs is a War on People

video | April 14, 2020

The War on Drugs was launched in the United States by former President Richard Nixon in 1971. This allowed for the criminalization of drug use, which led to the mass incarceration of millions of Americans, particularly for communities of color....

Watch Now

Hydroxychloroquine's false hope: How an obscure drug became a coronavirus cure

video | April 13, 2020

Claims about hydroxychloroquine and chloroquine have taken hold of the global consciousness. Online conversations, media articles and politicians’ statements quickly - and incorrectly - labeled it as a ‘cure’ for covid-19, the disease caused by the novel coronavirus....

Watch Now

Spotlight

USP Zdrowie

USP Health is a market leader in over the counter and over-the-counter (OTC) markets in Poland. The company's portfolio includes well-known brands. Apap, Ibuprom, Gripex, Verdin, Stoperan and Xenna.

Events